Drug Trial Radar · NCT06833307
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Feb 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Feb 2025
Primary completion
Jul 2026
Study completion Aug 2026
Sponsor
- Lead sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 6 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess efficacy, safety of subcutaneous SHR-1314 in pediatric patients of age 6 to \<18 years with moderate-to-Severe plaque psoriasis
Conditions
- Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis
Interventions
SHR-1314Drug
SHR-1314: dose 1 SHR-1314:dose 2 SHR-1314:dose 3
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety assessment including adverse events at Week 16Time frame: Week 16
- PK parameters: Cmax at Week 12Time frame: Week 12
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Capital Medical University Affiliated Children's Hospital
Beijing, Beijing Municipality, China
Shanghai Huashan Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.